Skip to content

Laserdish Silicone Ventricular Lead W/Trailing Tin

by Telectronics Pacing Systems, Inc.

510(k) K903221

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK903221 Date8 Nov 1990ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a Permanent Pacemaker Electrode, designed as a ventricular lead for cardiac pacing applications. Constructed from silicone with a trailing tin component, it is intended for implantation within the heart to deliver electrical stimulation for rhythm regulation in patients with bradycardia or other pacing indications.

The Laserdish Silicone Ventricular Lead with Trailing Tin is supplied sterile and intended for single-use implantation. It is classified as a Class III device under FDA regulations, with a Traditional 510(k) clearance (K903221) and falls under the DTB product code. Compatible for use in cardiovascular procedures, it adheres to 870.3680 regulatory standards and is distributed in sterile packaging for surgical application.

Other devices from Telectronics Pacing Systems, Inc.

See all devices from Telectronics Pacing Systems, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Laserdish Silicone Ventricular Lead with Trailing Tin in clinical practice?

    This device is designed as a permanent pacemaker electrode specifically for ventricular lead placement. It delivers electrical stimulation to regulate heart rhythm in patients with bradycardia or other pacing-related conditions by implanting within the heart to ensure consistent pacing support.

  • Is this lead intended for single-use or reusable applications, and how is it packaged?

    The Laserdish Silicone Ventricular Lead is sterile and intended for single-use only after implantation. It is supplied in sterile packaging, ensuring readiness for surgical use without requiring reprocessing.

  • What regulatory pathway was followed for FDA clearance of this ventricular lead?

    This device received FDA clearance through a Traditional 510(k) pathway (K903221), classified as a Class III device under FDA regulations. It adheres to the DTB product code and 870.3680 regulatory standards, with a decision of *Substantially Equivalent* by the Cardiovascular (CV) Advisory Committee.

  • What materials is the lead constructed from, and how does the trailing tin component contribute to its function?

    The lead is constructed primarily from silicone, a durable and biocompatible material ideal for long-term cardiac implantation. The trailing tin component likely serves as a conductive element, ensuring reliable electrical contact for pacing stimuli within the heart’s ventricular chamber.

  • How should this lead be stored before use, given its sterile and single-use nature?

    Since the lead is sterile and single-use, it should be stored in its original, unopened packaging in a clean, dry environment away from direct sunlight or extreme temperatures. Follow manufacturer guidelines to preserve sterility until immediate preoperative use.